SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
Datum | Rating | Analyst | |
---|---|---|---|
17.10.18 | Roche buy | Jefferies & Company Inc. | |
17.10.18 | Novartis Neutral | JP Morgan Chase & Co. | |
15.10.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
15.10.18 | Roche overweight | JP Morgan Chase & Co. | |
12.10.18 | Novartis buy | Baader Bank | |
11.10.18 | Novartis Neutral | JP Morgan Chase & Co. | |
11.10.18 | Novartis Neutral | JP Morgan Chase & Co. | |
10.10.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
10.10.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
08.10.18 | Roche overweight | JP Morgan Chase & Co. | |
03.10.18 | Roche overweight | JP Morgan Chase & Co. | |
02.10.18 | Roche overweight | JP Morgan Chase & Co. | |
28.09.18 | Roche Hold | Deutsche Bank AG | |
28.09.18 | Novartis Hold | Deutsche Bank AG | |
25.09.18 | Roche overweight | JP Morgan Chase & Co. | |
25.09.18 | Novartis Neutral | UBS AG | |
25.09.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
25.09.18 | Roche overweight | JP Morgan Chase & Co. | |
20.09.18 | Novartis Equal weight | Barclays Capital | |
19.09.18 | Roche Neutral | UBS AG | |
14.09.18 | Roche Neutral | UBS AG | |
14.09.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
11.09.18 | Novartis buy | Citigroup Corp. | |
11.09.18 | Novartis Neutral | UBS AG | |
11.09.18 | Roche Underperform | BNP PARIBAS | |
11.09.18 | Novartis Neutral | BNP PARIBAS | |
10.09.18 | Roche Neutral | Merrill Lynch & Co., Inc. | |
10.09.18 | Novartis buy | Merrill Lynch & Co., Inc. | |
07.09.18 | Novartis buy | Jefferies & Company Inc. | |
07.09.18 | Roche buy | Jefferies & Company Inc. | |
07.09.18 | Roche overweight | JP Morgan Chase & Co. | |
06.09.18 | Novartis buy | Kepler Cheuvreux | |
06.09.18 | Novartis Neutral | JP Morgan Chase & Co. | |
08.08.18 | Roche Hold | Kepler Cheuvreux | |
02.08.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
30.07.18 | Roche overweight | Barclays Capital | |
27.07.18 | Roche buy | S&P Capital IQ | |
27.07.18 | Roche Reduce | HSBC | |
27.07.18 | Roche Underperform | Credit Suisse Group | |
27.07.18 | Roche Hold | Deutsche Bank AG |